Blood Cancer Journal

Fig. 3: Survival according to the melphalan dose received at diagnosis. | Blood Cancer Journal

Fig. 3: Survival according to the melphalan dose received at diagnosis.

From: Treatment and outcomes of patients with light chain amyloidosis who received a second line of therapy post autologous stem cell transplantation

Fig. 3

Search

Advanced search

Quick links